China Healthcare : Voluntary Announcement

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA HEALTHCARE ENTERPRISE GROUP LIMITED

華 夏健 康產 業集團 有 限公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

VOLUNTARY ANNOUNCEMENT

This announcement is made by China Healthcare Enterprise Group Limited (the''Company'') on a voluntary basis to keep the shareholders and potential investors of the Company informed of the update of the latest development of the Company and its subsidiaries (the''Group'').

The board (the''Board'') of directors (the''Directors'') of the Company wishes to inform the shareholders and potential investors of the Company that the Board is in negotiation with Mr. Yang Zhihui (''Mr. Yang'') in relation to a proposed acquisition of a group of companies (the''Proposed Acquisition'') principally engaged in healthcare business in the People's Republic of China. Mr. Yang is the ultimate controlling shareholder of the Company holding approximately 30.6% shareholding interest of the Company as at the date of this announcement, and hence a connected person.

If the Proposed Acquisition materializes, it will constitute a connected transaction under Chapter 14A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the''Listing Rules'') and a very substantial acquisition and a reverse takeover involving a new listing application under Chapter 14 of the Listing Rules.

For the purpose of the Proposed Acquisition, the Company on 27 June 2017 submitted an enquiry to The Stock Exchange of Hong Kong Limited to consult whether the Company can proceed with the Proposed Acquisition.

The Company will make further announcement(s) in relation to the Proposed Acquisition in accordance with the requirements of the Listing Rules as and when appropriate.

Shareholders and the potential investors of the Company should note that the Proposed Acquisition may or may not proceed, and they are advised to exercise caution when dealing in the securities of the Company.

By order of the Board of

China Healthcare Enterprise Group Limited Gong Shaoxiang

Chairman and Executive Director

Hong Kong, 27 June 2017

As at the date of this announcement, the Board comprises Mr. Gong Shaoxiang (Chairman), Mr. Lee Chi Hwa Joshua and Mr. Duan Chuanhong as executive Directors, Mr. Cao Yuyun and Mr. Chan Kin Sang as non-executive Directors and Mr. Bao Jinqiao, Mr. Wong Chun Hung and Mr. Leung Pok Man as independent non-executive Directors.